IQVIA

We are proud to launch our 2023 Environmental, Social and Governance Report, which details our progress on our sustainability commitments and initiatives over the last year. To read more, visit https://bit.ly/3STeTor. #IQVIAESG #ESGReport

Download the IQVIA Institute annual Global Oncology Trends 2024 report here: https://bit.ly/3wP6knG hashtag#Oncology hashtag#CancerResearch hashtag#LifeSciences hashtag#GlobalHealth

Venture to Poland to explore how to use #realworlddata to make sophisticated patient-centric decisions. Join Andrzej Mazurek, Katarzyna Sosnowska, Mateusz Łuczko, and Amy Roach for Exploring Real World Data in Poland. https://bit.ly/4b2b5rJ #RWD #patientcare

Launch excellence has become a rare achievement. Hear from our expert Kirstie Scott, Senior Consultant, EMEA Thought Leadership team, and don’t miss the resources we created for you to develop a successful #launch strategy. https://bit.ly/3KKXqdW #LaunchExcellence

#DIA2024 is fast approaching – two of the events we’re most excited about are panel discussions on the evolving role of #RealWorldData in clinical and regulatory decision-making.    Join IQVIA’s Christina Mack, Chief Scientific Officer, RWS, as she speaks with industry and regulatory experts about the latest regulatory perspectives, guidance and best practices for integrating RWD into innovative research and how new technologies offer new possibilities for improved patient care. More info on both of her two discussions below:    Tuesday June 18: Christina joins Dr. Rachele Hendricks-Sturrup from Duke-Margolis Institute for Health Policy, Catherine Lerro from the FDA and Mehmet Burcu from Merck to discuss evolving guidance and best practices for use of RWD for regulatory approval. We’ll share case examples that illustrate the integration of innovative RWD in study designs.    Thursday June 20: Christina sits down for a discussion moderated by Nancy A. Dreyer alongside Paul Strijbos from Roche, Jeffrey Siegel from the FDA and Martha Azer from Johnson & Johnson. They’ll speak to practical applications of person-generated health data, including how new data captures the patient voice and the new opportunities this provides for patient-centricity.    Looking forward to further connecting at DIA!   https://lnkd.in/gRdK8STc

Obesity could impact 1 adult out of 4 of the world’s adults by 2035. The high and growing burden of cardiometabolic diseases presents a major #PublicHealth challenge with vast economic impact, running into the trillions of dollars. Be at the forefront with our latest Thought Leadership insights on #obesity, and get in touch with an IQVIA expert: https://bit.ly/3xhBLag

If you would like to gain a strategic advantage with unique insights, check out the newly released IQVIA Trial Link solution below. It provides you with a detailed view of the active clinical trial landscape worldwide to help you understand more deeply the future competitive market. Click through and request a demo to find out how it can help you refine and optimize your business planning.

Still looking through lists of medical experts to find the KOL you need? IQVIA’s Expert Ecosystem empowers you to easily identify and validate rising stars, experts, and high-volume physicians globally. https://bit.ly/3z27Nrp #KeyOpinionLeaders #MedicalAffairs #KOLs

IQVIA values career exploration so you can fully achieve your career aspirations. Mother of two, Dana Joyner, took her career from #Clinical Trials Assistant to Business Operations and Capabilities Director at IQVIA. Read full blog here: https://bit.ly/4bV3pJp #WeAreIQVIA

Register today for our Virtual Conference on June 26-27 and explore the latest perspectives on innovation in #RWE and Medical Affairs. Join IQVIA and industry experts for sessions discussing the importance of Clinical Outcome Assessments in RW studies, the integration of RWE into Medical Affairs, a deep dive into the next steps of implementation for the EU JCA, and improving patient outcomes with the assistance of AI and RWD. https://bit.ly/4cfRlSt